Cala Medical limited, formed in February 2017, is a spin out from the University of Limerick . The company have designed and patented a unique device containing a specific immobilized enzyme which treats the excessive inflammatory response in the blood of sepsis patients. The treatment could dramatically cut the death rate from sepsis which is a highly prevalent and often fatal illness requiring intensive medical care.